Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

Cell

Volumn 73, Issue 3, 1993, Pages 457-467

  Pfeffer, Klaus ^a   Matsuyama, Toshifumi ^a   Kündig, Thomas M ^a   Wakeham, Andrew ^a   Kishihara, Kenji ^a   Shahinian, Arda ^a   Wiegmann, Katja ^b   Ohashi, Pamela S ^a   Krönke, Martin ^b   Mak, Tak W ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CELL SURFACE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; GENE TARGETING; HOST RESISTANCE; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; T LYMPHOCYTE;

ANIMAL; BASE SEQUENCE; CELL NUCLEUS; CLONING, MOLECULAR; HUMAN; IMMUNITY, NATURAL; KINETICS; LIPOPOLYSACCHARIDES; LISTERIA INFECTIONS; LIVER; LYMPHOCYTES; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; RADIOLIGAND ASSAY; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR NECROSIS FACTOR;

ANIMALIA; BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES;

EID: 0027297663     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(93)90134-C     Document Type: Article

References (73)

1. Characterization of the Misf system. I. A novel “polymorphism” of endogenous superantigens
2. Mis—a retrovirus exploits the immune system
3. Biology of multifunctional cytokines: II 6 and related molecules (II 1 and TNF)
4. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin
5. Tumor necrosis, cachexia, shock, and inflammation: a common mediator
6. The biology of cachectin/TNF—a primary mediator of the host response
7. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
8. TNF in Legionella infection
9. Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity
10. Embryo-derived stem cells: a tool for elucidating the developmental genetics of the mouse
11. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines
12. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor
13. TNF in Malaria
14. Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development
15. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism
16. Interleukin-1: an immunological perspective
17. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes
18. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
19. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity
20. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
21. Linkage of Mis genes to endogenous mammary tumour viruses of inbred mice
22. CD8 is needed for development of cytotoxic T cells but not helper T cells
23. Constitutive synthesis of tumor necrosis factor in the thymus
24. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia
25. Virus proteins that counteract host immune defenses
26. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor
27. TNF and Mycobacteria
28. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein
29. Characterization of endogenous and exogenous mouse mammary tumor virus proviral DNA with site-specific molecular clones
30. Role of tumor necrosis factor in Listeria resistance of nude mice
31. Production of tumor necrosis factor during murine listeriosis
32. Evidence that tumor necrosis factor has an important role in antibacterial resistance
33. The p70 tumor necrosis factor receptor mediates cytotoxicity
34. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures
35. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor binding protein
36. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding
37. Human tumor necrosis factor increases the resistance against Listeria infection in mice
38. A standardized nomenclature for endogenous mouse mammary tumor viruses
39. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor
40. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
41. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
42. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
43. Tumor necrosis factor alpha induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor alpha-chain expression in primary human T lymphocytes
44. A new superfamily of cell surface proteins related to the nerve growth factor receptor
45. The Staphylococcal enterotoxins and their relatives
46. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor
47. Endotoxins and disease mechanisms
48. TNF in Listeriosis
49. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection
50. Protective effect of recombinant tumor necrosis factor-alpha in murine salmonellosis
51. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells
52. Soluble forms of tumor necrosis factor receptors (TNF-Rs)
53. Expression of tumor necrosis factor at a specific stage of mouse embryos
54. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
55. Lymphotoxin
56. Human rTNF-alpha augments antibacterial resistance in mice: potentiation of its effects by recombinant human rIL-1
57. Molecular cloning and expression of a receptor for human tumor necrosis factor
58. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown
59. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors
60. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
61. Two TNF receptors
62. The two different receptors for tumor necrosis factor mediate distinct cellular responses
63. Identification of a 60 kd tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses
64. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
65. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells
66. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice
67. Shock and tissue injury induced by recombinant human cachectin
68. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
69. The pathophysiology of tumor necrosis factor
70. The lps gene
71. Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice
72. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades
73. Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells